Cancers | Selected Papers in 2023 in the Section “Cancer Drug Development”

We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Drug Development”. The list of relevant papers can be seen below.

“Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment”
by Hiroyoshi Y. Tanaka, Takuya Nakazawa, Atsushi Enomoto, Atsushi Masamune and Mitsunobu R. Kano
Cancers 2023, 15(3), 724; https://doi.org/10.3390/cancers15030724
Available online: https://www.mdpi.com/2072-6694/15/3/724

“Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers”
by Shoaib Shoaib, Farheen Badrealam Khan, Meshari A. Alsharif, M. Shaheer Malik, Saleh A. Ahmed, Yahya F. Jamous, Shahab Uddin, Ching Siang Tan, Chrismawan Ardianto, Saba Tufail et al.
Cancers 2023, 15(8), 2390; https://doi.org/10.3390/cancers15082390
Available online: https://www.mdpi.com/2072-6694/15/8/2390

“Multi-Fold Computational Analysis to Discover Novel Putative Inhibitors of Isethionate Sulfite-Lyase (Isla) from Bilophila wadsworthia: Combating Colorectal Cancer and Inflammatory Bowel Diseases”
by Muhammad Waqas, Sobia Ahsan Halim, Atta Ullah, Assim Alaa Mohammed Ali, Asaad Khalid, Ashraf N. Abdalla, Ajmal Khan and Ahmed Al-Harrasi
Cancers 2023, 15(3), 901; https://doi.org/10.3390/cancers15030901
Available online: https://www.mdpi.com/2072-6694/15/3/901

“Precision Medicine: Disease Subtyping and Tailored Treatment”
by Richard C. Wang and Zhixiang Wang
Cancers 2023, 15(15), 3837; https://doi.org/10.3390/cancers15153837
Available online: https://www.mdpi.com/2072-6694/15/15/3837

“Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies”
by Dilipkumar Pal, Khushboo Raj, Shyam Sundar Nandi, Surajit Sinha, Abhishek Mishra, Arijit Mondal, Ricardo Lagoa, Jack T. Burcher and Anupam Bishayee
Cancers 2023, 15(10), 2808; https://doi.org/10.3390/cancers15102808
Available online: https://www.mdpi.com/2072-6694/15/10/2808

“microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer”
by Naotake Funamizu, Masahiko Honjo, Kei Tamura, Katsunori Sakamoto, Kohei Ogawa and Yasutsugu Takada
Cancers 2023, 15(4), 1230; https://doi.org/10.3390/cancers15041230
Available online: https://www.mdpi.com/2072-6694/15/4/1230

“Iridoid Derivatives as Anticancer Agents: An Updated Review from 1970–2022”
by Tanaka Ndongwe, Bwalya A. Witika, Nontobeko P. Mncwangi, Madan S. Poka, Phumzile P. Skosana, Patrick H. Demana, Beverley Summers and Xavier Siwe-Noundou
Cancers 2023, 15(3), 770; https://doi.org/10.3390/cancers15030770
Available online: https://www.mdpi.com/2072-6694/15/3/770

“Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors”
by Lucía Pérez-Lamas, Alejandro Luna, Concepción Boque, Blanca Xicoy, Pilar Giraldo, Raúl Pérez López, Concepción Ruiz Nuño, Natalia De las Heras, Elvira Mora Casterá, Javier López Marín et al.
Cancers 2023, 15(4), 1045; https://doi.org/10.3390/cancers15041045
Available online: https://www.mdpi.com/2072-6694/15/4/1045

“An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models”
by Donald Poirier, Jenny Roy, René Maltais, Cindy Weidmann and Étienne Audet-Walsh
Cancers 2023, 15(11), 3033; https://doi.org/10.3390/cancers15113033
Available online: https://www.mdpi.com/2072-6694/15/11/3033

“α-Mangostin Promotes In Vitro and In Vivo Degradation of Androgen Receptor and AR-V7 Splice Variant in Prostate Cancer Cells”
by Mirielle C. Nauman, Jong Hoon Won, Sakina M. Petiwala, Bhaskar Vemu, Hyun Lee, Maria Sverdlov and Jeremy J. Johnson
Cancers 2023, 15(7), 2118; https://doi.org/10.3390/cancers15072118
Available online: https://www.mdpi.com/2072-6694/15/7/2118

“Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance”
by Tapan K. Maity, Eun Young Kim, Constance M. Cultraro, Abhilash Venugopalan, Leena Khare, Ramulu Poddutoori, Sivapriya Marappan, Samiulla D. Syed, William G. Telford, Susanta Samajdar et al.
Cancers 2023, 15(8), 2263; https://doi.org/10.3390/cancers15082263
Available online: https://www.mdpi.com/2072-6694/15/8/2263

“Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds”
by Neeraj Choudhary, Sweta Bawari, Jack T. Burcher, Dona Sinha, Devesh Tewari and Anupam Bishayee
Cancers 2023, 15(15), 3980; https://doi.org/10.3390/cancers15153980
Available online: https://www.mdpi.com/2072-6694/15/15/3980

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office